MD-7246, a Delayed-Release Formulation of Linaclotide Targeting Visceral Pain Associated With IBS-D, Does Not Impact Bowel Frequency or Stool Consistency in Healthy Volunteers: Results From Phase I Trial: 497
AMERICAN JOURNAL OF GASTROENTEROLOGY（2019）
关键词
visceral pain associated,bowel frequency,linaclotide,stool consistency,delayed-release
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要